E815
TEAS SECTION 8 & 15 RECEIVED
06/02/2026
Back to search
Official data from USPTO
IMMUNOVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/03/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
07/15/2019
Registration date
08/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/18/2020
Last transaction
06/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
DURHAM, NC, US
Examiner
LIEBL, ALEXANDRA
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a Y-shaped antibody symbol with the word "IMMUNOVANT" appearing to the right of the symbol.
Holders and representatives
Holders
I. C. (pessoa física)
Immunovant Sciences GmbH
Immunovant Sciences GmbH
Representatives
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of immune system related diseasesdisorders and conditions; pharmaceutical preparations for human use for the treatment of autoimmune diseasesdisorders and conditions; biological preparations for medical and therapeutic use for the treatment of immune system related diseasesdisorders and conditions; biological preparations for medical and therapeutic use for the treatment of autoimmune diseasesdisorders and conditions; pharmaceutical and biological preparations for medical and therapeutic use for treating immune system related diseasesdisorders and conditions; pharmaceutical and biological preparations for medical and therapeutic use for treating autoimmune diseasesdisorders and conditions
Class 42
Scientific and technological servicesmedical researchscientific research and analysisdiagnostic services in the fields of immunology and autoimmunity; biomedical and pharmaceutical research services; scientific research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; providing scientific research information relating to scientific research in the field of pharmaceuticals and biomedicine
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
27 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/13/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/19/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/19/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/19/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/19/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/19/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/19/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2020
PUBO
PUBLISHED FOR OPPOSITION
06/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/27/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/24/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/24/2019
GNRT
NON-FINAL ACTION E-MAILED
10/24/2019
CNRT
NON-FINAL ACTION WRITTEN
10/24/2019
DOCK
ASSIGNED TO EXAMINER
10/16/2019
DOCK
ASSIGNED TO EXAMINER
10/01/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2019
NWAP
NEW APPLICATION ENTERED
07/18/2019
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.